Drug Shortage Report for ADMELOG

Last updated on 2022-06-02 History
Report ID 160685
Drug Identification Number 02469901
Brand name ADMELOG
Common or Proper name Insulin lispro
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) INSULIN LISPRO
Strength(s) 100UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 10 mL vial, 1 vial/box
ATC code A10AB
ATC description INSULINS AND ANALOGUES
Reason for shortage Other (Please describe in comments)
Anticipated start date 2022-05-25
Actual start date 2022-06-01
Estimated end date 2022-08-30
Actual end date
Shortage status Actual shortage
Updated date 2022-06-02
Company comments Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2022-06-02 English Compare
v7 2022-06-01 French Compare
v6 2022-06-01 English Compare
v5 2022-05-31 French Compare
v4 2022-05-31 English Compare
v3 2022-05-26 English Compare
v2 2022-05-16 French Compare
v1 2022-05-16 English Compare

Showing 1 to 8 of 8